Durable biventricular assist device support for 1212 days as a bridge to heart transplantation.
J Surg Case Rep
; 2023(7): rjad372, 2023 Jul.
Article
de En
| MEDLINE
| ID: mdl-37416492
ABSTRACT
Experience with durable biventricular assist devices (BiVADs) as a bridge to heart transplantation (HTx) is limited, particularly in women. A 41-year-old woman with biventricular failure complicated by cardiogenic shock underwent durable concurrent BiVAD implantation and was supported for 1212 days as a bridge to HTx. During BiVAD support, she experienced bacteremia (day 1030 of support), appropriately managed with intravenous antibiotics. She is alive and well, 1479 days from BiVAD implantation and 267 days from orthotopic HTx. Strategies contributing to successful prolonged support include concurrent BiVAD implantation, aggressive cardiac rehabilitation, diet management for weight loss and frequent interval surveillance.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
J Surg Case Rep
Année:
2023
Type de document:
Article
Pays d'affiliation:
États-Unis d'Amérique